James Orsini

Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death

Jessica K. Altman, Alfred Rademaker, Elizabeth H. Cull et al. · Leukemia Research · 2013 · 134 citations

Medicine, Hematology, Oncology +11

Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer

Mark A. Socinski, Corey J. Langer, Isamu Okamoto et al. · Annals of Oncology · 2012 · 107 citations

Medicine, Oncology, Pharmacology +9

Safety and efficacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer

Mark A. Socinski, Isamu Okamoto, Jeremy K. Hon et al. · Annals of Oncology · 2013 · 66 citations

Medicine, Oncology, Pharmacology +10

Patient-Reported Neuropathy and Taxane-Associated Symptoms in a Phase 3 Trial of nab-Paclitaxel Plus Carboplatin versus Solvent-Based Paclitaxel Plus Carboplatin for Advanced Non–Small-Cell Lung Cancer

Vera Hirsh, Isamu Okamoto, Jeremy K. Hon et al. · Journal of Thoracic Oncology · 2013 · 34 citations · Full text

Medicine, Oncology, Pharmacology +13

Evaluation of Circulating Tumor DNA for Methylated <i>BCAT1</i> and <i>IKZF1</i> to Detect Recurrence of Stage II/Stage III Colorectal Cancer (CRC)

Benjamin Musher, Joshua Melson, Gianni Amato et al. · Cancer Epidemiology Biomarkers & Prevention · 2020 · 34 citations · Full text

Medicine, Oncology, Gastrointestinal Oncology +16